The Bahamas steps forward: the new law positioning the country as a global reference in longevity and regenerative therapies

The Bahamas has decided to move decisively into one of the fastest-growing sectors worldwide: longevity medicine and regenerative therapies. With the entry into force of the Longevity and Regenerative Therapies Act (LARTA), the archipelago introduces an advanced legal framework that places the country firmly on the global map of medical innovation, clinical research and high-end health tourism.

This legislation goes far beyond a statement of intent. It establishes a complete regulatory architecture designed to attract scientific talent, international investment and patients seeking advanced treatments within a safe, transparent and closely supervised environment.

A legal framework designed for the future of medicine

LARTA sets out clear rules for the approval, oversight and monitoring of advanced therapies, including cellular treatments, gene-based approaches and regenerative solutions focused on healthy ageing. Unlike other destinations where medical innovation often operates in regulatory grey areas, the Bahamas has chosen a model that combines agility with institutional control.

At the heart of the system are two newly created bodies:

• The National Longevity and Regenerative Therapy Board, responsible for defining policy, evaluating projects and coordinating the development of the country’s longevity ecosystem.

• The Ethics Review Committee, tasked with reviewing every proposal from an ethical, scientific and patient-protection perspective.

This dual-layer structure positions the Bahamas as a jurisdiction where innovation advances hand in hand with responsibility—an essential factor for a senior population that is increasingly informed and discerning.

Longevity, ethics and trust: a new strategic triangle

For the 50+ generation, the rise of regenerative therapies brings both opportunity and caution. One of LARTA’s most compelling strengths lies in its emphasis on ethics and traceability as core pillars of the model.

Every authorised centre must comply with international standards, report outcomes, undergo regular audits and operate within digital monitoring systems. Penalties for non-compliance are clearly defined, reinforcing confidence among international patients seeking cutting-edge treatments without unnecessary risk.

Premium medical tourism: a new opportunity for the FIFTIERS generation

The Bahamas has long been associated with wellbeing, an exceptional climate and exclusivity. With this new law, the country adds a powerful new dimension: becoming a reference destination for personalised longevity programmes.

For professionals, investors and patients over 50, a new landscape emerges—one where advanced medicine is seamlessly integrated with recovery experiences, prevention strategies and long-term quality of life in settings designed for extended stays. Specialised clinics, medical resorts and research centres now operate within a stable legal framework that supports growth and innovation.

A model other countries will closely observe

The Longevity and Regenerative Therapies Act also introduces a system of periodic policy review, allowing regulations to evolve every two years in line with scientific and technological progress. This flexibility turns the Bahamas into a regulatory laboratory that many countries are likely to watch closely over the coming decade.

In a world where population ageing represents one of the major economic and social challenges ahead, the Bahamas has chosen to move early. Not only as a tourism destination, but as an emerging player in the global longevity economy.

The FIFTIERS perspective

For the FIFTIERS community, this development reinforces a clear trend: longevity is no longer just about adding years, but about strategic decisions, intelligent regulation and access to responsible medical innovation. The Bahamas has understood the moment. The rest of the world is now beginning to look toward the Caribbean with renewed attention.